Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Biological
  • Participants: 464
  • Start Date: October 1, 2020
Efficacy and Safety of Recombinant Zoster Vaccine in Stable SLE Patients(Vtrial)
Clinical Trial
  • Status: Recruiting
  • Phase: Early Phase 1
  • Intervention Type: Biological, Drug
  • Participants: 250
  • Start Date: September 1, 2020
Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents: A Randomized, Doubled-Blinded, Comparative Group Observational Study
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 140
  • Start Date: July 28, 2020
Persistence of Protection Conferred by Shingrix Against Herpes Zoster
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other
  • Participants: 100
  • Start Date: July 2020
VACcination of LIver Transplantation Candidates: Efficacy, Tolerance and Acceptability Prospective Cohort Study.
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Biological
  • Participants: 840
  • Start Date: May 22, 2020
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Biological
  • Participants: 426
  • Start Date: April 8, 2020
Convalescent Plasma Therapy From Recovered Covid-19 Patients as Therapy for Hospitalized Patients With Covid-19
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 170
  • Start Date: February 28, 2020
Hypogammaglobulinemia and Immunization Responses to Measles in Rituximab-treated Multiple Sclerosis Patients
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Biological
  • Participants: 30
  • Start Date: January 30, 2020
Safety and Immunogenicity of Recombinant Glycoprotein E Herpes Zoster Subunit (HZ/su) Vaccine in Renal Transplant Recipients
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Biological
  • Participants: 60
  • Start Date: November 14, 2019
SHINGRIX-Systems Biology of Zoster Vaccine Recombinant, Adjuvanted
Showing 1-12 of 27